ATM gene

Aliases

AT M, ATM, ATM gene, ATM protein, Ataxia Telangiectasia Mutated, Ataxia telangiectasia mutated, P-ATM, ataxia telangiectasia mutated, phospho-ATM

External links

NCBI Gene · Ensembl · GeneCards · UniProt

No related entities found.

Mentioned in (40)

Papers in which this entity is mentioned.

• Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort. (2026)
• Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States. (2025)
• FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy. (2025)
• Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy. (2024)
• Heritable defects in telomere and mitotic function selectively predispose to sarcomas. (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology. (2021)
• Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. (2021)
• Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. (2021)
• Pan-cancer analysis of whole genomes. (2020)
• Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
• Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. (2019)
• Pan-cancer whole-genome analyses of metastatic solid tumours. (2019)
• Mutational processes shape the landscape of TP53 mutations in human cancer. (2018)
• Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes. (2018)
• Tumor fraction in cell-free DNA as a biomarker in prostate cancer. (2018)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes (2018)
• Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations. (2018)
• Patterns and mechanisms of structural variations in human cancer. (2018)
• HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. (2017)
• Universal Patterns of Selection in Cancer and Somatic Tissues. (2017)
• Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. (2017)
• Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. (2017)
• Copy-number signatures and mutational processes in ovarian carcinoma (2017)
• Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. (2016)
• Landscape of somatic mutations in 560 breast cancer whole-genome sequences. (2016)
• Integrative clinical genomics of advanced prostate cancer. (2015)
• Germline Mutations in Predisposition Genes in Pediatric Cancer. (2015)
• Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. (2014)
• Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. (2014)
• Involvement of p53 in the repair of DNA double strand breaks: multifaceted Roles of p53 in homologous recombination repair (HRR) and non-homologous end joining (NHEJ). (2014)
• Clonal evolution in hematological malignancies and therapeutic implications. (2014)
• Exon identity crisis: disease-causing mutations that disrupt the splicing code. (2014)
• Ewing sarcoma protein: a key player in human cancer. (2013)
• RNA splicing: a new player in the DNA damage response. (2013)
• Pan-cancer patterns of somatic copy number alteration. (2013)
• BRCA1 and BRCA2: different roles in a common pathway of genome protection. (2011)
• Functional consequences of developmentally regulated alternative splicing. (2011)
• Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. (2009)
• MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. (2008)

Merged raw entities (7)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.